Alamar Biosciences, Inc.
ALMR- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0002104204
No open-market purchases or sales by Alamar Biosciences, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $664.3M in total; 3 superinvestors hold it, including ARK Invest and HHLR Advisors (Hillhouse).
Holders of 5% or more of ALMR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alamar Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. | 13G | 10.20%7.07M shares | New | Aug 11, 20261 filing | Aug 11, 2026 | SEC |
| Illumina Innovation Fund II, L.P. | 13D | 9.60%6.36M shares | New | Apr 23, 20261 filing | Apr 23, 2026 | SEC |
| Sherpa Healthcare Fund II, L.P. | 13G | 7.20%4.97M shares | New | Jul 2, 20261 filing | Jul 2, 2026 | SEC |
| Luo Yuling | 13G | 6.40%4.53M shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 13D/A | 6.10%4.23M shares | −0.20 ppfrom 6.30% | Apr 23, 20262 filings | Jul 7, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Alamar Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20265:07 PM ET | Luo Yuling | 13G | 6.40%4.53M shares | New | Jun 30, 2026 | SEC |
| Aug 11, 20264:39 PM ET | Qiming Corporate GP VI, Ltd.and 6 others | 13G | 10.20%7.07M shares | New | Jun 30, 2026 | SEC |
| Jul 7, 20264:55 PM ET | Sands Capital Life Sciences Pulse Fund II, L.P.and 2 others | 13D/A | 6.10%4.23M shares | −0.20 ppfrom 6.30% | Jul 5, 2026 | SEC |
| Jul 2, 20268:46 AM ET | Sherpa Healthcare Fund II, L.P.and 4 others | 13G | 7.20%4.97M shares | New | Apr 16, 2026 | SEC |
| Apr 23, 20264:24 PM ET | Illumina Innovation Fund II, L.P.and 4 others | 13D | 9.60%6.36M shares | New | Apr 20, 2026 | SEC |
| Apr 23, 20261:57 PM ET | Sands Capital Life Sciences Pulse Fund II, L.P.and 2 others | 13D | 6.30%4.23M shares | New | Apr 16, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alamar Biosciences, Inc. shares.
No Form 144 notices for Alamar Biosciences, Inc. are on file.